Patent details
EP1740180 Title: USE OF FLIBANSERIN IN THE TREATMENT OF PREMENSTRUAL DISORDERS
Basic Information
- Publication number:
- EP1740180
- PCT Application Number:
- PCT/EP/2005/004086
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP057354201
- PCT Publication Number:
- WO/2005/102343
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF FLIBANSERIN IN THE TREATMENT OF PREMENSTRUAL DISORDERS
- French Title of Invention:
- UTILISATION DE FLIBANSERINE DANS LE TRAITEMENT DES TROUBLES PREMENSTRUELS
- German Title of Invention:
- VERWENDUNG VON FLIBANSERIN BEI DER BEHANDLUNG VON PRÄMENSTRUELLEN STÖRUNGEN
- SPC Number:
Dates
- Filing date:
- 18/04/2005
- Grant date:
- 21/07/2010
- EP Publication Date:
- 21/07/2010
- PCT Publication Date:
- 03/11/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/01/2007
- EP B1 Publication Date:
- 21/07/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/04/2011
- Expiration date:
- 18/04/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/04/2005
- Name:
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Address:
- Binger Strasse 173, 55216 Ingelheim, Germany (DE)
- Name:
- Boehringer Ingelheim Pharmaceuticals Inc.
- Address:
- 900 Ridgebury Road, Ridgefield Connecticut 06877, United States (US)
Inventor
- Name:
- PYKE Robert
- Address:
- United States (US)
Priority
- Priority Number:
- 564660 P
- Priority Date:
- 22/04/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/496;
| Filing date | Document type | Number of pages |
|---|